Publications by authors named "Susan Danehower"

Claim this Profile
S
Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living with HIV-1 Treated with Ritonavir-Boosted Fosamprenavir Oral Solution-Based Antiretroviral Therapy.
Lisa L Ross, Mark F Cotton, Haseena Cassim, Harmony P Garges, Sven C van Dijkman, Susan Danehower

AIDS Res Hum Retroviruses· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design of 8-hydroxyquinoline tetracyclic lactams as HIV-1 integrase strand transfer inhibitors.
Emile J Velthuisen, Brian A Johns, David P Temelkoff, Kevin W Brown, Susan C Danehower

Eur J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and Structural Characterization of Rotamers of C-C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096.
Wieslaw M Kazmierski, Susan Danehower, Maosheng Duan, Robert G Ferris, Vassil Elitzin

ACS Med Chem Lett· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.
Stephen Jenkinson, Michael Thomson, David McCoy, Mark Edelstein, Susan Danehower

Antimicrob Agents Chemother· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.
Glen Lutchman, Susan Danehower, Byung-Cheol Song, T Jake Liang, Jay H Hoofnagle

Gastroenterology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults.
Peter J Ruane, David M Parenti, David M Margolis, David H Shepp, Timothy J Babinchak, Susan A Danehower

HIV Clin Trials· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic effects of zidovudine 600 mg once/day versus 300 mg twice/day in therapy-naïve patients infected with human immunodeficiency virus.
Peter J Ruane, Gary J Richmond, Edwin DeJesus, Christina E Hill-Zabala, Susan C Danehower

Pharmacotherapy· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Amy C Justice, Daniel S Stein, Gregory P Fusco, Beth H Sherrill, Jennifer S Fusco, Susan C Danehower

J Clin Epidemiol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy.
Cynthia McCoig, Maria Mercedes Castrejón, Elizabeth Castaño, Onix De Suman, Carmen Báez, Susan Danehower

J Pediatr· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis